Article Text
Summary
Myeloid sarcoma (MS) is a rare condition that most commonly occurs in the setting of acute myeloidleukaemia (AML) or other chronic myeloproliferative disorders. It presents as an abnormal growth that can develop anywhere in the human body, and its clinical manifestations are often non-specific.
We present the case of a patient admitted to the emergency room with bowel obstruction. After careful clinical assessment, she underwent a right hemicolectomy. After a thorough examination of the surgical pathology specimen, including testing a wide array of immunohistochemical markers, the patient was timely diagnosed with MS, allowing for the implementation of the appropriate treatment to achieve complete remission. This is crucial, since non-leukaemic patients with untreated MS always progress to AML, and have a better prognosis if adequate therapy is implemented early. Our patient is now in the second postoperative year and shows no signs of relapse.
- small intestine cancer
- gastrointestinal surgery
- surgical oncology
- malignant and benign haematology
- pathology
Statistics from Altmetric.com
Footnotes
Contributors RAN contributed to the surgical procedure, collected the data, performed the literature search, wrote the manuscript and reviewed the final version. BC performed the surgical procedure and contributed to the literature search and to the revision of the manuscript. CA performed the pathological analysis and contributed to the manuscript’s revision. JSL critically reviewed the final version.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.